4-methoxyamphetamine has been researched along with Ewing Sarcoma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertucci, F; Blay, JY; Bompas, E; Boudou-Rouquette, P; Brahmi, M; Cancel, M; Duffaud, F; Dufresne, A; Firmin, N; Gantzer, J; Gaspar, N; Jean-Denis, M; Le Loarer, F; Marec-Bérard, P; Perrin, C; Pierron, G; Ray-Coquard, I; Tirode, F; Toulmonde, M; Valentin, T; Watson, S | 1 |
| Ledford, H | 1 |
2 other study(ies) available for 4-methoxyamphetamine and Ewing Sarcoma
| Article | Year |
|---|---|
Patterns of care and outcome of CIC-rearranged sarcoma patients: A nationwide study of the French sarcoma group.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Biomarkers, Tumor; Bone Neoplasms; Child; Child, Preschool; Death; Female; Humans; Male; Middle Aged; Oncogene Proteins, Fusion; Retrospective Studies; Sarcoma; Sarcoma, Ewing; Sarcoma, Small Cell; Skin Neoplasms; Soft Tissue Neoplasms; Young Adult | 2023 |
Cruel fusion: What a young man's death means for childhood cancer.
Topics: Adolescent; Death; Epigenesis, Genetic; Humans; Male; Oncogene Proteins, Fusion; Proto-Oncogene Protein c-fli-1; Receptor, IGF Type 1; Receptors, Somatomedin; RNA Interference; RNA-Binding Protein EWS; Sarcoma, Ewing | 2017 |